Ulasan PaxForex 2026
Ulasan lengkap PaxForex untuk trader Indonesia — regulasi, spread, dan biaya.
Regulasi di Indonesia
| Regulator | FSA FSA — Seychelles Financial Services Authority (FSA) |
| Nomor Lisensi | SD061 |
| Entitas Teregulasi | PaxForex Ltd |
| Leverage Maks (Forex) | 1:500 |
| Setoran Minimum | $10 |
| Spread EUR/USD | From 0.0 pips (ECN/Raw) |
| Instrumen | 150+ |
| Platform | MT4 |
| Copy Trading | ✗ |
| Saham Nyata | ✗ |
| Biaya tidak aktif | Tidak ada biaya tidak aktif |
Kesimpulan
Regulated by FSA (licence SD061). Minimum deposit $10. In Indonesia: maximum forex leverage 1:500.
About PaxForex
PaxForex was founded in 2010 and is headquartered in Victoria, Seychelles. The broker offers 150 tradeable instruments including forex pairs, CFDs on stocks, indices and commodities. It is regulated across multiple jurisdictions with a primary licence held by PaxForex Ltd under FSA.
In Indonesia, PaxForex operates as PaxForex Ltd, authorised by FSA under licence number SD061. Indonesia traders are subject to a maximum leverage of 1:500 on forex pairs under FSA rules.
Trading Platforms
Pros
- FSA regulated — licence SD061
- 150+ instruments to trade
- Negative balance protection in Indonesia
- Platforms: MT4
Cons
- Tidak ada biaya tidak aktif
- 76% of retail clients lose money
- CFD trading — you do not own the underlying asset
- No real stock ownership
Frequently Asked Questions
Apakah PaxForex diatur secara resmi?
PaxForex memiliki lisensi FSA nomor SD061, diterbitkan untuk {entity}. Dapat diverifikasi di register resmi FSA.
Berapa setoran minimum PaxForex di Indonesia?
Setoran minimum adalah $10. Jumlah ini diperlukan untuk membuka akun live untuk trader Indonesia di bawah regulasi FSA.
Berapa leverage yang ditawarkan PaxForex di Indonesia?
Di Indonesia, PaxForex menawarkan leverage forex maksimum 1:500 sesuai aturan FSA.
Apakah PaxForex aman untuk trading?
PaxForex diregulasi oleh FSA, yang mewajibkan pemisahan dana nasabah, perlindungan saldo negatif, dan audit independen.
Reader Comments
Loading comments...